Skip to main content
GMED logo

GMED · Globus Medical Inc

Track GMED — free
$85.90 -0.04 (-0.05%) At close · Aug 14
Market Cap
$11.53B
Shares
134.26M

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date Headline
2026-08-06 Globus Medical Reports Second Quarter 2026 Results

AUDUBON, Pa., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the second quarter ended June 30, 2026. Second Quarter 2026: Worldwide net sales were $789.6 million, an increase of 5.9%, or an

2026-07-16 Globus Medical Schedules Second Quarter Earnings Release and Conference Call

AUDUBON, Pa., July 16, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the second quarter ended June 30, 2026 after the market close on Thursday, August 6, 2026.

2026-05-07 Globus Medical Reports First Quarter 2026 Results

AUDUBON, Pa., May 07, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the first quarter ended March 31, 2026. First Quarter 2026: Worldwide net sales were $759.9 million, an increase of 27.0%, or an

2026-04-16 Globus Medical Schedules First Quarter Earnings Release and Conference Call

AUDUBON, Pa., April 16, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first quarter ended March 31, 2026 after the market close on Thursday, May 7, 2026.

2026-03-23 Globus Medical Announces Board Departure

AUDUBON, Pa., March 23, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced that John A. DeFord, PhD, a Director of Globus Medical Inc., notified the company of his decision to step down from the Board of Directors effective

2026-02-24 Globus Medical Reports Fourth Quarter and Full Year 2025 Results

AUDUBON, Pa., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter 2025: Worldwide net sales were $826.4 million, an

2026-02-12 Globus Medical Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

AUDUBON, Pa., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full-year ended December 31, 2025 after the market close on Tuesday, February 24, 2026.

2026-01-07 Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results

AUDUBON, Pa. , Jan. 07, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced preliminary unaudited sales results for the fourth quarter and full year ended December 31, 2025 . The company anticipates fourth quarter 2025 sales of

2025-11-06 Globus Medical Reports Third Quarter 2025 Results

AUDUBON, Pa. , Nov. 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2025 . Worldwide net sales were $769.0 million , an increase of 22.9%, or an increase of 22.3%

2025-10-16 Globus Medical Schedules Third Quarter Earnings Release and Conference Call

AUDUBON, Pa. , Oct. 16, 2025 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the third quarter ended September 30, 2025 after the market close on Thursday, November 6, 2025 .

2025-10-14 Globus Medical Launches ANTHEM™ Elbow Fracture System: A Comprehensive Plating Portfolio for Complex Elbow Trauma

AUDUBON, Pa. , Oct. 14, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, has announced the launch of the ANTHEM™ Elbow Fracture System , a fully comprehensive plating portfolio designed to address a wide spectrum of elbow fractures.

2025-08-28 Globus Medical, Inc. Secures Jury Verdict in Delaware Patent Litigation Against Life Spine, Inc.

AUDUBON, Pa. , Aug. 28, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, announced that a Delaware jury has returned a verdict in favor of Globus in its patent infringement litigation against Life Spine, Inc.

Past events

Source: https://investors.globusmedical.com/

Key facts CIK 1237831 CUSIP 379577208 13F (30d) 543 filings 538 filers Visit website Investor relations